These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 23990192

  • 1. Antazoline for rapid termination of atrial fibrillation during ablation of accessory pathways.
    Piotrowski R, Kryński T, Baran J, Futyma P, Stec S, Kułakowski P.
    Cardiol J; 2014; 21(3):299-303. PubMed ID: 23990192
    [Abstract] [Full Text] [Related]

  • 2. Radiofrequency catheter ablation of accessory pathways during pre-excited atrial fibrillation: acute success rate and long-term clinical follow-up results as compared to those patients undergoing successful catheter ablation during sinus rhythm.
    Kose S, Amasyali B, Aytemir K, Can I, Kilic A, Kursaklioglu H, Iyisoy A, Isik E.
    Heart Vessels; 2005 Jul; 20(4):142-6. PubMed ID: 16025362
    [Abstract] [Full Text] [Related]

  • 3. Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart.
    Bińkowski BJ, Makowski M, Kubiński P, Lubiński A.
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):169-173. PubMed ID: 29623481
    [Abstract] [Full Text] [Related]

  • 4. [High frequency catheter ablation of left-sided manifest accessory conduction pathways during sinus rhythm and in continuous atrial fibrillation].
    Chen X, Hindricks G, Kottkamp H, Willems S, Haverkamp W, Borggrefe M, Breithardt G.
    Z Kardiol; 1994 Apr; 83 Suppl 5():121-5. PubMed ID: 7846941
    [Abstract] [Full Text] [Related]

  • 5. Signal-averaged P wave in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation.
    Maia IG, Cruz Filho FE, Fagundes ML, Boghossian SH, Vanheusden L, Sa RM, Alves PA.
    J Am Coll Cardiol; 1995 Nov 01; 26(5):1310-4. PubMed ID: 7594048
    [Abstract] [Full Text] [Related]

  • 6. Dependency on atrial electrophysiological properties of appearance of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome: evidence from atrial vulnerability before and after radiofrequency catheter ablation and surgical cryoablation.
    Muraoka Y, Karakawa S, Yamagata T, Matsuura H, Kajiyama G.
    Pacing Clin Electrophysiol; 1998 Feb 01; 21(2):438-46. PubMed ID: 9507546
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF Study).
    Maciag A, Farkowski MM, Chwyczko T, Beckowski M, Syska P, Kowalik I, Pytkowski M, Wozniak J, Dabrowski R, Szwed H.
    Europace; 2017 Oct 01; 19(10):1637-1642. PubMed ID: 28339554
    [Abstract] [Full Text] [Related]

  • 8. Early repolarization in the inferior leads after accessory pathway ablation is highly correlated with atrial fibrillation in Wolff-Parkinson-White syndrome.
    Chen M, Wang Q, Sun J, Zhang PP, Li W, Mo BF, Li YG.
    J Cardiol; 2020 Mar 01; 75(3):323-329. PubMed ID: 31445855
    [Abstract] [Full Text] [Related]

  • 9. Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study).
    Farkowski MM, Maciag A, Kowalik I, Konka M, Szwed H, Pytkowski M.
    Br J Clin Pharmacol; 2019 Jul 01; 85(7):1552-1558. PubMed ID: 30920001
    [Abstract] [Full Text] [Related]

  • 10. Radiofrequency catheter ablation at the non-coronary cusp for the treatment of para-hisian accessory pathways.
    Xu G, Liu T, Liu E, Ye L, Shehata M, Wang X, Li G.
    Europace; 2015 Jun 01; 17(6):962-8. PubMed ID: 25355782
    [Abstract] [Full Text] [Related]

  • 11. Atrial vulnerability is a major mechanism of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
    Zhang Y, Wang L.
    Med Hypotheses; 2006 Jun 01; 67(6):1345-7. PubMed ID: 16697118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
    Duckeck W, Kuck KH.
    Herz; 1993 Feb 01; 18(1):60-6. PubMed ID: 8454253
    [Abstract] [Full Text] [Related]

  • 16. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study.
    Pappone C, Vicedomini G, Manguso F, Baldi M, Pappone A, Petretta A, Vitale R, Saviano M, Ciaccio C, Giannelli L, Calovic Z, Tavazzi L, Santinelli V.
    Circulation; 2012 Feb 07; 125(5):661-8. PubMed ID: 22215859
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
    Hamada T, Hiraki T, Ikeda H, Kubara I, Yoshida T, Ohga M, Imaizumi T.
    J Cardiovasc Electrophysiol; 2002 Mar 07; 13(3):223-9. PubMed ID: 11942586
    [Abstract] [Full Text] [Related]

  • 19. Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients.
    Pappone C, Vicedomini G, Manguso F, Saviano M, Baldi M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Cuko A, Calovic Z, Fundaliotis A, Moscatiello M, Tavazzi L, Santinelli V.
    Circulation; 2014 Sep 02; 130(10):811-9. PubMed ID: 25052405
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.